Similar articles

• Response to Kujawa et al. letter-to-the-editor.

  Sethuraman G, Taylor CC, Enerson M, Dunayevich E. Sethuraman G, et al. Schizophr Res. 2006 May;84(1):172-3. doi: 10.1016/j.schres.2005.11.010. Epub 2006 Mar 24. Schizophr Res. 2006. PMID: 16563702 No abstract available.
• Utilization of long-acting antipsychotic medication in patient care.

  Kane JM. Kane JM. CNS Spectr. 2006 Dec;11(12 Suppl 14):1-7; quiz 7-8. doi: 10.1017/s1092852900025852. CNS Spectr. 2006. PMID: 17146411 Review.
• Psychopharmacotherapy and remission of patients with schizophrenia.

  Degmecić D, Pozgain I, Filaković P, Dodig-Curković K, Mihanović M. Degmecić D, et al. Coll Antropol. 2009 Jun;33(2):547-51. Coll Antropol. 2009. PMID: 19662777
• Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.

  Novick D, Haro JM, Suarez D, Lambert M, Lépine JP, Naber D. Novick D, et al. Psychopharmacology (Berl). 2007 May;191(4):1015-22. doi: 10.1007/s00213-007-0730-2. Epub 2007 Feb 20. Psychopharmacology (Berl). 2007. PMID: 17310386 Clinical Trial.
• [Maintenance pharmacotherapy of schizophrenia: remission and the effectiveness of long-acting risperidone therapy].

  Sárosi A. Sárosi A. Neuropsychopharmacol Hung. 2006 Dec;8(4):179-87. Neuropsychopharmacol Hung. 2006. PMID: 17211053 Review. Hungarian.